Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07014462. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review
ClinicalTrials.gov study NCT03047083. IPD Sharing: NO. Countries: 1. Publications: 0.
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07177079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1)
ClinicalTrials.gov study NCT01146977. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00795548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01126814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02610062. IPD Sharing: NO. Countries: 2. Publications: 0.
Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02715011. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05319587. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05470140. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece
ClinicalTrials.gov study NCT05317494. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07053020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01090167. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study the Novel Functions and Molecular Mechanisms of Vascular Endothelial Growth Factor-C (VEGF-C) in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01195506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05144243. IPD Sharing: YES. Countries: 1. Publications: 0.
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT06379360. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
ClinicalTrials.gov study NCT03356080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00136461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation
ClinicalTrials.gov study NCT04691648. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03915379. IPD Sharing: YES. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.